Page last updated: 2024-10-24

protein trimerization

Definition

Target type: biologicalprocess

The formation of a protein trimer, a macromolecular structure consisting of three noncovalently associated identical or nonidentical subunits. [GOC:hjd]

Protein trimerization is a fundamental biological process where three individual protein monomers assemble into a stable, functional trimeric complex. This process is crucial for a wide range of cellular activities, including enzyme catalysis, signal transduction, and structural support. Here's a detailed breakdown of the process:

**1. Monomer Interactions:**
The initial step involves the interaction between two monomers, forming a dimer. This interaction is driven by various non-covalent forces, such as hydrogen bonding, electrostatic interactions, hydrophobic interactions, and van der Waals forces. The specific amino acid residues involved in the interaction are often located in specific regions called "interaction interfaces."

**2. Trimer Formation:**
Once the dimer is formed, a third monomer interacts with the dimer to create the trimer. This interaction can be either identical or different from the dimerization interaction, depending on the specific protein. The trimerization process can be influenced by various factors, including:

- **Protein Concentration:** A higher concentration of monomers favors trimer formation.
- **Environmental Conditions:** Factors like pH, temperature, and the presence of cofactors can influence the stability and kinetics of trimerization.
- **Chaperones:** Some proteins require the assistance of molecular chaperones to facilitate proper folding and assembly into trimers.

**3. Trimer Stability:**
The trimer structure is typically more stable than individual monomers or dimers. This increased stability arises from multiple factors, including:

- **Increased Surface Area:** The trimer has a larger surface area than individual monomers, leading to greater interactions with the surrounding environment.
- **Enhanced Hydrophobic Interactions:** The trimer often buries more hydrophobic residues within its core, increasing its overall stability.
- **Cooperative Binding:** The binding of one monomer to the dimer can increase the affinity of the other two monomers, enhancing overall stability.

**4. Functional Significance:**
Trimerization plays a vital role in various biological processes:

- **Enzyme Catalysis:** Trimeric enzymes can exhibit enhanced catalytic activity compared to their monomeric counterparts.
- **Signal Transduction:** Trimeric complexes can act as receptors or signal transduction pathways, mediating the response to external stimuli.
- **Structural Support:** Trimers can provide structural integrity to cells and tissues, forming components of the cytoskeleton or extracellular matrix.

**5. Examples:**
Numerous proteins form trimers, including:

- **Collagen:** A fibrous protein essential for connective tissue structure.
- **Immunoglobulin G (IgG):** An antibody involved in the immune response.
- **ATP Synthase:** An enzyme that synthesizes ATP, the primary energy currency of cells.

In conclusion, protein trimerization is a complex and highly regulated process involving the assembly of three protein monomers into a stable trimer. This process is crucial for a wide range of biological functions, highlighting the importance of protein interactions and assembly in maintaining cellular homeostasis and carrying out vital biological activities.'
"

Proteins (1)

ProteinDefinitionTaxonomy
HLA class II histocompatibility antigen gamma chainAn MHC class II histocompatibility antigen gamma chain that is encoded in the genome of human. [PRO:WCB, UniProtKB:P04233]Homo sapiens (human)

Compounds (2)

CompoundDefinitionClassesRoles
crizotinibcrizotinib : A 3-[1-(2,6-dichloro-3-fluorophenyl)ethoxy]-5-[1-(piperidin-4-yl)pyrazol-4-yl]pyridin-2-amine that has R configuration at the chiral centre. The active enantiomer, it acts as a kinase inhibitor and is used for the treatment of patients with locally advanced or metastatic non-small cell lung cancer (NSCLC)

Crizotinib: A piperidine and aminopyridine derivative that acts as an inhibitor of RECEPTOR PROTEIN-TYROSINE KINASES, including ANAPLASTIC LYMPHOMA KINASE (ALK) and HEPATOCYTE GROWTH FACTOR RECEPTOR (HGFR; c-Met). It is used in the treatment of NON-SMALL CELL LUNG CANCER.
3-[1-(2,6-dichloro-3-fluorophenyl)ethoxy]-5-[1-(piperidin-4-yl)pyrazol-4-yl]pyridin-2-amineantineoplastic agent;
biomarker;
EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitor
pf-06463922lorlatinib : A cyclic ether that is 16,17-dihydro-2H-8,4-(metheno)pyrazolo[4,3-h][2,5,11]benzoxadiazacyclotetradecin-15(10H)-one substituted by methyl groups at positions 2 and 10R, and by cyano, amino and fluoro groups at positions 3, 7 and 12 respectively. It is a small molecule inhibitor of ALK and ROS1 kinase developed by Pfizer for the treatment of ALK-positive non-small cell lung cancer.

lorlatinib: inhibits both anaplastic lymphoma kinase and c-ros oncogene 1 (ROS1) protein
aminopyridine;
aromatic ether;
azamacrocycle;
benzamides;
cyclic ether;
monofluorobenzenes;
nitrile;
organic heterotetracyclic compound;
pyrazoles
antineoplastic agent;
EC 2.7.10.1 (receptor protein-tyrosine kinase) inhibitor